InforMS: Winter 2025

FEATURED ARTICLES

MORE FROM THIS ISSUE

MS Research Today: Expanding Horizons

From new treatment targets and trial designs to broader inclusion and predictive biomarkers, MS research is entering a new era focused on progression, precision, and quality of life.   For...

Remembering Patricia Daily

We are saddened to share the news of the passing of our colleague and friend, Patricia Daily. Many in our community knew Pat, worked alongside her, or benefited from her...

BTK Inhibitors: A New Class Focused on Progression

A research emphasis on measuring relapses and tracking MRIs naturally leads to a treatment emphasis on preventing relapses and reducing MRI activity. And of course, both are still important. But...

Lifestyle and Brain Health: What You Can Influence

One encouraging thread across recent studies is how daily habits can build cognitive reserve — the brain’s ability to work around damage — while also improving mood, sleep, and physical...

The Evolving Research of Discontinuing DMTs

One of the most common topics that comes up in RMMSC education programs and Q&A sessions is the question of discontinuing disease-modifying therapies (DMTs). Patients want to know when they...

Moving the Needle: One Participant’s Journey Through MS Research

For this issue of InforMS, we sat down with David Dombeck, a research participant at the Rocky Mountain MS Center at the University of Colorado. David was diagnosed later in...

Investing in Innovation: How Grassroots Research Funding Turns Bold Ideas into Better Care

Meaningful progress in multiple sclerosis research often begins with a single question. But those questions may not always fit the requirements of large federal or medical industry grants. Research that...